SmarTex Compression Therapies
Smart garments for medical compression therapy
At a glance
-
Development stage
Proof-of-concept
-
Investment stage
Dont' know / not relevant
-
UNSW affiliation
Spinout - staff led
-
Technology readiness level
TRL-3
SmarTex Compression Therapies create smartphone-controlled compression garments that provide dynamic compression therapy.
With patented technology and strong clinical validation, SmarTex targets a growing market of chronic venous and lymphatic disease patients to improve adherence and clinical outcomes.
-
SmarTex develops smart, wearable sleeves that deliver active compression therapy using patented hydraulic textile actuators. Controlled via a smartphone app, the device enables real-time, user-friendly pressure adjustment to improve adherence and outcomes. The team combines expertise in biomedical engineering, soft robotics, and vascular surgery to design clinically informed, patient-centred solutions. SmarTex generates revenue through direct sales to clinics and individuals, with plans for reimbursement pathways and remote monitoring services.
-
- Chronic conditions such as lymphoedema and venous insufficiency affect approximately 6 million Australians and require long-term compression therapy.
- Static compression garments remain difficult to don and adjust, while pneumatic devices are bulky, expensive, and restrict mobility.
- These limitations reduce patient adherence, compromise treatment outcomes, and place additional strain on healthcare systems.
-
- Lymphoedema clinics
- Physiotherapists
- Home-care providers
-
- Filed international patent (PCT) for core technology
- Demonstrated compression motion with proof-of-concept prototype
- Received positive feedback from early users on comfort and usability
Discover more UNSW spinouts
Search our catalogue of active spinouts and tech for license.